Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 13, 2015 10:32 PM ET

Healthcare Providers and Services

Company Overview of Pathway Genomics Corporation

Company Overview

Pathway Genomics Corporation operates a clinical laboratory to provide commercial genetic testing services to physicians and their patients in the United States and internationally. Its testing services cover various conditions, including cancer risk, cardiac health, inherited diseases, and nutrition and exercise response, as well as drug response for specific medications that are used in pain management and mental health. The company offers BRCATrue, BreastTrue high risk panel, ColoTrue, LynchSyndromeTrue, familial studies program, and genetic variant reclassification tests for cancer; pharmacogenomics related tests that comprise cardiac, mental health, medication, and pain medication DNA i...

4045 Sorrento Valley Boulevard

San Diego, CA 92121

United States

Founded in 2008





Key Executives for Pathway Genomics Corporation

Founder, Chief Executive Officer and President
Vice President of Finance
President of Pathway Genomics International
Chief Technology Officer and Vice President of Engineering & Product Development
Chief Innovation Officer
Compensation as of Fiscal Year 2015.

Pathway Genomics Corporation Key Developments

Pathway Genomics Appoints Paul Sonnier to Strategic Advisory Board

Pathway Genomics Corporation announced that Paul Sonnier, digital health advocate and social entrepreneur, is joining the company’s Strategic Advisory Board. Mr. Sonnier is globally recognized for his digital health advocacy, including promulgation of a modern definition of digital health that incorporates the impact of both the digital and genetics revolutions on health, healthcare, living, and society.

Pathway Genomics Corporation Appoints Peter Pace to Board of Directors

Pathway Genomics Corporation announced that the sixteenth chairman of the Joint Chiefs of Staff, retired U.S. Marine General Peter Pace is joining the company’s board of directors.

Pathway Genomics Corporation Appoints Jim Plante to Industry Trade Advisory Committee

Pathway Genomics Corporation announced that Founder and CEO Jim Plante has been appointed by the U.S. Secretary of Commerce, Penny Pritzker, and U.S. Trade Representative (USTR), Ambassador Michael Froman to the Industry Trade Advisory Committee on Chemicals, Pharmaceuticals, Health and Science Products (ITAC 3). As a member of ITAC, Mr. Plante will provide the President, through the Commerce Secretary and the Office of the United States Trade Representative (USTR), with detailed policy and technical advice, information, and recommendations regarding trade barriers, negotiation of trade agreements, and implementation of existing trade agreements affecting industry sectors. His term expires February 2018.

Similar Private Companies By Industry

Company Name Region
Community Hospice, Inc. United States
Apex Men's Health United States
UnitedHealthcare of Oklahoma, Inc. United States
Spinal Metrx Corporation United States
Broadway Services, Inc. United States

Recent Private Companies Transactions

Private Placement
November 12, 2014

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Pathway Genomics Corporation, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at